News

FDA Awards Six Grants for Rare Disease Clinical Trials

FDA Awards Six Grants for Rare Disease Clinical Trials

The U.S. Food and Drug Administration announced that it awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years. These trial research grants, awarded through the Congressionally funded Orphan Products Grants Program, enhance the development of medical products for patients with rare diseases. Yourway fully understands the challenges conducting clinical trials for rare diseases, and provides a range of integrated solutions to overcome them.

Back to Index
Media

Upcoming Event

Media

Articles

Staying Ahead of COVID-19

Open chat
Come chat with us!
Hello! How can I help you?